reports
Harvard Bioscience, Inc. to Participate in the Benchmark Healthcare Ho...
Harvard Bioscience, Inc. to Participate in the Benchmark Healthcare House Call Virtual Conference HOLLISTON, Mass., May 16, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green, Chairman and Chief Executive Officer, and Jennifer Cote, Chief Financial Officer, will be participating in the Benchmark Healthcare House Call Virtual Conference on May 22nd, 2024, with a live fireside chat scheduled for 9:00-9:40 am ET. The Company will also be hosting one-on-one meetings with investors in conjunction with the Conference. To register for the presentatio...
Vincerx Pharma Reports First Quarter 2024 Financial Results and Provid...
Vincerx Pharma Reports First Quarter 2024 Financial Results and Provides Corporate Update Vincerx continued to progress Phase 1 dose-escalation studies for VIP943, a potentially best-in-class anti-CD123 antibody-drug conjugate (ADC), and VIP236, a first-in-class small molecule-drug conjugate (SMDC) The National Institutes of Health (NIH) and Vincerx announced positive results from enitociclib Phase 1 combination study, reporting a fourth partial response (PR) in a patient with peripheral T-cell lymphoma (PTCL) Vincerx reported the first PR in a patient with transformed follicular lymphoma...
Harvard Bioscience Announces First Quarter 2024 Financial Results
Harvard Bioscience Announces First Quarter 2024 Financial Results Strong gross margin performance and focus on efficiency to support ongoing investments in growth HOLLISTON, Mass., May 07, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced financial results for the first quarter ended March 31, 2024. Jim Green, Chairman and CEO, said, “As expected, our first quarter revenues reflect ongoing market headwinds, especially in APAC, amplified by a strong prior year comparison. Despite these headwinds, we were pleased to deliver gross margins of ...
- Wedbush Research
2454 MEDIATEK INC.
VMW VMWARE INC. CLASS A
QRVO QORVO INC.
SHAK SHAKE SHACK INC. CLASS A
ERIC B TELEFONAKTIEBOLAGET LM ERICSSON CLASS B
WLDN WILLDAN GROUP
WFC WELLS FARGO & COMPANY
WEN WENDY'S COMPANY
WDC WESTERN DIGITAL CORPORATION
TXRH TEXAS ROADHOUSE INC.
SQ SQUARE INC. CLASS A
SIMON SILICON MOTION TECHNOLOGY CORPORATION SPONSORED ADR
RWT REDWOOD TRUST INC.
RARE ULTRAGENYX PHARMACEUTICAL INC.
QCOM QUALCOMM INC
PSTG PURE STORAGE INC. CLASS A
NVDA NVIDIA CORPORATION
NTAP NETAPP INC.
MXL MAXLINEAR INC
MU MICRON TECHNOLOGY INC.
MELI MERCADOLIBRE INC.
KURA KURA ONCOLOGY INC.
INTC INTEL CORPORATION
FTNT FORTINET INC.
EXPE EXPEDIA GROUP INC.
CYBR CYBERARK SOFTWARE LTD.
CROX CROCS INC.
AXTI AXT INC.
ARDX ARDELYX INC
WD WALKER & DUNLOP INC.
BJRI BJ'S RESTAURANTS INC.
GRBK GREEN BRICK PARTNERS
2330 TAIWAN SEMICONDUCTOR MANUFACTURING CO. LTD.
2303 UNITED MICROELECTRONICS CORP.
HPE HEWLETT PACKARD ENTERPRISE CO.
FND FLOOR & DECOR HOLDINGS INC. CLASS A
CELH CELSIUS HOLDINGS INC.
VTR VENTAS INC.
AMD ADVANCED MICRO DEVICES INC.
AAPL APPLE INC.
MSFT MICROSOFT CORPORATION
IBM INTERNATIONAL BUSINESS MACHINES CORPORATION
BKNG BOOKING HOLDINGS INC.
AVGO BROADCOM INC.
DELL DELL TECHNOLOGIES INC CLASS C
PEAK HEALTHPEAK PROPERTIES INC.
SMCI SUPER MICRO COMPUTER
RKT INC.
ABNB ROCKET COMPANIES
ELEV AIRBNB INC. CLASS A
LBPH ELEVATION ONCOLOGY
MRVL LONGBOARD PHARMACEUTICALS
STX MARVELL TECHNOLOGY INC
GFS SEAGATE TECHNOLOGY HLDGS PLC
COIN GLOBALFOUNDRIES INC
DBD COINBASE GLOBAL INC
NCR DIEBOLD NIXDORF INC
NCR NIGERIA
- Brian Violino
- Henry Coffey
- Jay McCanless
American Assets Trust, Inc. Reports First Quarter 2024 Financial Resul...
American Assets Trust, Inc. Reports First Quarter 2024 Financial Results Net income available to common stockholders of $19.3 million for the first quarter, or $0.32 per diluted share. Funds from Operations ("FFO") per diluted share increased 8% year-over-year for the first quarter to $0.71 per diluted share. Increased 2024 FFO per diluted share guidance to a range of $2.24 to $2.34 with a midpoint of $2.29, a 1% increase over prior guidance. SAN DIEGO, April 30, 2024 (GLOBE NEWSWIRE) -- American Assets Trust, Inc. (NYSE: AAT) (the ...
Harvard Bioscience Schedules First Quarter 2024 Earnings Conference Ca...
Harvard Bioscience Schedules First Quarter 2024 Earnings Conference Call for May 7, 2024 at 8:00 AM ET HOLLISTON, Mass., April 29, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for the quarter ended March 31, 2024 before the market opens on May 7, 2024, and will hold a conference call to discuss the results at 8:00 a.m. Eastern Time. Participants who would like to join the call and ask a question must register . Once registered, you will receive the dial-in numbers and a unique PIN number. Participants who would like to join the a...
UMB Announces Agreement to Acquire Heartland Financial
UMB Announces Agreement to Acquire Heartland Financial Largest acquisition in UMB history will increase total assets by more than 40% and significantly expand geographic footprint UMB investment community call today, Monday, April 29, at 7:30 a.m. (CT) / 8:30 a.m. (ET) KANSAS CITY, Mo. and DENVER, April 29, 2024 (GLOBE NEWSWIRE) -- UMB Financial Corporation (Nasdaq: UMBF) and Heartland Financial, USA Inc. (Nasdaq: HTLF) announced today that they have entered into a definitive merger agreement under which UMB Financial Corporation (UMB) will acquire Heartland Financial USA, Inc. (HTLF),...
Heartland Financial USA, Inc. ("HTLF") Reports Quarterly Results as of...
Heartland Financial USA, Inc. ("HTLF") Reports Quarterly Results as of March 31, 2024 First Quarter Highlights •Quarterly net income available to common stockholders of $49.7 million or $1.16 per common share•Adjusted earnings available to common stockholders of $52.4 million or $1.22 adjusted diluted earnings per common share, which excludes $1.4 million of acquisition, integration and restructuring costs and $2.0 million of FDIC special assessment expense•Common equity ratio increased to 9.76%; Tangible common equity ratio (non-GAAP) improved 35 basis points to 6.88%•Net interest margin,...
Vincerx Pharma Announces Pricing of Underwritten Public Offering of Co...
Vincerx Pharma Announces Pricing of Underwritten Public Offering of Common Stock and Warrants PALO ALTO, Calif., April 25, 2024 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC) today announced the pricing of an underwritten public offering of (i) 6,000,000 shares of its common stock and accompanying common stock warrants to purchase an aggregate of 6,000,000 shares of common stock, and (ii) to certain investors, pre-funded warrants to purchase up to an aggregate of 16,000,000 shares of common stock and accompanying common stock warrants to purchase up to an aggregate of 16,000,000 ...
Heartland Financial USA, Inc. (“HTLF”) Announces Common Stock and Seri...
Heartland Financial USA, Inc. (“HTLF”) Announces Common Stock and Series E Preferred Stock Dividends DENVER, April 25, 2024 (GLOBE NEWSWIRE) -- Common Stock Dividend Heartland Financial USA, Inc. (NASDAQ: HTLF), operating under the brand name HTLF, announced its Board of Directors approved a quarterly cash dividend on common stock of $0.30 per share. The dividend is payable on May 28, 2024, to stockholders of record at the close of business on May 13, 2024. HTLF has increased or maintained its common stock dividend every quarter for more than 40 years. Series E Preferred Stock Divid...
Vincerx Pharma Announces Proposed Underwritten Public Offering of Comm...
Vincerx Pharma Announces Proposed Underwritten Public Offering of Common Stock and Warrants PALO ALTO, Calif., April 25, 2024 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC) today announced a proposed underwritten public offering of shares of its common stock and accompanying common stock warrants to purchase shares of its common stock and, to certain investors, pre-funded warrants to purchase shares of common stock and accompanying common stock warrants to purchase shares of its common stock. All of the shares, pre-funded warrants and common stock warrants in the proposed offerin...
HBT Financial, Inc. Announces First Quarter 2024 Financial Results
HBT Financial, Inc. Announces First Quarter 2024 Financial Results First Quarter Highlights Net income of $15.3 million, or $0.48 per diluted share; return on average assets (“ROAA”) of 1.23%; return on average stockholders' equity (“ROAE”) of 12.42%; and return on average tangible common equity (“ROATCE”)(1) of 14.83%Adjusted net income(1) of $18.1 million; or $0.57 per diluted share; adjusted ROAA(1) of 1.45%; adjusted ROAE(1) of 14.72%; and adjusted ROATCE(1) of 17.57%Asset quality remained strong with nonperforming assets to total assets of 0.20%, close to a historic lowNet interest ma...
- Wedbush Research
PMT PENNYMAC MORTGAGE INVESTMENT TRUST
WDC WESTERN DIGITAL CORPORATION
UMH UMH PROPERTIES INC.
SIMON SILICON MOTION TECHNOLOGY CORPORATION SPONSORED ADR
RWT REDWOOD TRUST INC.
RARE ULTRAGENYX PHARMACEUTICAL INC.
QCOM QUALCOMM INC
PSTG PURE STORAGE INC. CLASS A
NVDA NVIDIA CORPORATION
NTAP NETAPP INC.
NRZ NEW RESIDENTIAL INVESTMENT CORP.
MXL MAXLINEAR INC
MU MICRON TECHNOLOGY INC.
MFA MFA FINANCIAL INC.
INTC INTEL CORPORATION
GOOGL ALPHABET INC. CLASS A
AXTI AXT INC.
ABR ARBOR REALTY TRUST INC.
WD WALKER & DUNLOP INC.
SWKS SKYWORKS SOLUTIONS INC.
2330 TAIWAN SEMICONDUCTOR MANUFACTURING CO. LTD.
2303 UNITED MICROELECTRONICS CORP.
AMZN AMAZON.COM INC.
AMD ADVANCED MICRO DEVICES INC.
AAPL APPLE INC.
MSFT MICROSOFT CORPORATION
AVGO BROADCOM INC.
RC READY CAPITAL CORPORATION
COOP MR. COOPER GROUP INC.
SMCI SUPER MICRO COMPUTER
PFSI INC.
RKT PENNYMAC FINANCIAL SERVICES INC.
GHLD ROCKET COMPANIES
MRVL GUILD HOLDINGS
STX MARVELL TECHNOLOGY INC
UWMC SEAGATE TECHNOLOGY HLDGS PLC
GFS UWM HLDGS CORP
EWTX GLOBALFOUNDRIES INC
CAVA EDGEWISE THERAPEUTICS INC
CAVA GROUP INC
- Brian Violino
- Henry Coffey
- Jay McCanless
UMH UMH PROPERTIES INC.
RWT REDWOOD TRUST INC.
NRZ NEW RESIDENTIAL INVESTMENT CORP.
MFA MFA FINANCIAL INC.
ABR ARBOR REALTY TRUST INC.
WD WALKER & DUNLOP INC.
RC READY CAPITAL CORPORATION
COOP MR. COOPER GROUP INC.
PFSI PENNYMAC FINANCIAL SERVICES INC.
RKT ROCKET COMPANIES
GHLD GUILD HOLDINGS
UWMC UWM HLDGS CORP
HTLF Schedules First Quarter Earnings Conference Call for May 1, 2024
HTLF Schedules First Quarter Earnings Conference Call for May 1, 2024 DENVER, April 15, 2024 (GLOBE NEWSWIRE) -- HTLF (NASDAQ: HTLF) today announced the company will host a conference call detailing its first quarter 2024 financial results at 5 p.m. ET on Wednesday, May 1, 2024. Bruce K. Lee, President and CEO, and Kevin L. Thompson, Chief Financial Officer, will conduct the conference call. There will be a question-and-answer session for analysts following the presentation. Financial results will be available on the company’s website on May 1, 2024, after market close. To access the ...
HBT Financial, Inc. to Announce First Quarter 2024 Financial Results o...
HBT Financial, Inc. to Announce First Quarter 2024 Financial Results on April 22, 2024 BLOOMINGTON, Ill., April 11, 2024 (GLOBE NEWSWIRE) -- HBT Financial, Inc. (NASDAQ: HBT) (the “Company” or “HBT Financial”), the holding company for Heartland Bank and Trust Company, today announced that it will issue its first quarter 2024 financial results before the market opens on Monday, April 22, 2024. A copy of the press release announcing the first quarter 2024 financial results and an investor presentation will be made available on the Company’s investor relations website at . About HBT Financi...
Harvard Bioscience Announces Action to Improve Operational Efficiency ...
Harvard Bioscience Announces Action to Improve Operational Efficiency and Support Ongoing Investments in Growth HOLLISTON, Mass., April 09, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced a labor force reduction to improve its operating cost structure and support its ongoing investments in growth. The Company expects to realize overall annual run rate savings of approximately $4 million beginning in the second quarter of 2024. The Company also expects second quarter restructuring-related charges of approximately $0.5 million. Jim Green, Harvard Bioscienc...
Vincerx Pharma Presents Positive Preliminary Phase 1 Data for VIP236 a...
Vincerx Pharma Presents Positive Preliminary Phase 1 Data for VIP236 and Updates on Pipeline Progress at the American Association for Cancer Research (AACR) Annual Meeting 2024 VIP236 demonstrated positive signs of clinical activity, including tumor reduction, and an improved safety profile in heavily pretreated patients with metastatic solid tumors VIP943 pharmacokinetic (PK) data shows very little free payload in circulation, consistent with the favorable safety profile observed preclinically and clinically In preclinical studies, Vincerx’s next-generation effector chemistry improves t...
American Assets Trust, Inc. Announces First Quarter 2024 Earnings Rele...
American Assets Trust, Inc. Announces First Quarter 2024 Earnings Release Date and Conference Call Information SAN DIEGO, April 08, 2024 (GLOBE NEWSWIRE) -- American Assets Trust, Inc. (NYSE:AAT) (the “Company”) will announce its first quarter 2024 earnings in a press release to be issued after the market closes on Tuesday, April 30, 2024. Senior management will hold a conference call for its first quarter 2024 earnings on Wednesday, May 1, 2024 at 8:00 a.m. Pacific Time. To access the conference call, please dial 1 (833) 816-1162 and ask to join the American Assets Trust, Inc. Conferen...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.